Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Yes, I understood that to be the case as has been talked about here. They did not list the January 2019 presentation on the Investor's page so I missed it.
What is the upside of continuing dosing patients for such length in time when as has been mentioned that events generally happen at the front end of the trial? Or am I wrong?
